FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308393306> ?p ?o ?g. }

• W4308393306 endingPage "113959" @default.
• W4308393306 startingPage "113959" @default.
• W4308393306 abstract "Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) bring significant benefits to non-small cell lung cancer patients with EGFR mutations, which represent a breakthrough in lung cancer therapy. However, patients will ultimately develop the acquired resistance to the first- or second-generation EGFR-TKIs after a period of treatment, and EGFR T790M mutation is the most common resistant mechanism. The third-generation EGFR-TKIs target T790M mutation and show potent anti-tumor efficacy, especially in central neural system response. Unfortunately, patients inevitably get resistant to the third-generation EGFR-TKIs due to various mechanisms, which can be mainly divided into EGFR-dependent and -independent ones. EGFR-dependent mechanism refers to manifold EGFR mutations while EGFR-independent mechanisms include bypass signal activation, histologic transformation and so on. To precisely address this issue and improve clinical outcomes, various other therapies (e.g. chemotherapy, radiotherapy, etc.) in combination with the third-generation EGFR-TKIs are designed. However, the current results of combination therapies are insufficient and ambiguous, which remain further exploration. Herein, we provide an updated landscape of the third-generation EGFR-TKIs and elaborate on the complex resistant mechanisms. Notably, we summarize the combination therapies with third-generation EGFR-TKIs and discuss their limitations and future perspective, aiming at providing insights to clinicians from bench to bedside." @default.
• W4308393306 created "2022-11-11" @default.
• W4308393306 creator A5009303145 @default.
• W4308393306 creator A5021464011 @default.
• W4308393306 creator A5059265428 @default.
• W4308393306 creator A5061661472 @default.
• W4308393306 creator A5063958770 @default.
• W4308393306 creator A5066716873 @default.
• W4308393306 creator A5074278109 @default.
• W4308393306 creator A5083853001 @default.
• W4308393306 creator A5085143863 @default.
• W4308393306 date "2022-12-01" @default.
• W4308393306 modified "2023-10-18" @default.
• W4308393306 title "The prospect of combination therapies with the third-generation EGFR-TKIs to overcome the resistance in NSCLC" @default.
• W4308393306 cites W1703561559 @default.
• W4308393306 cites W1760215417 @default.
• W4308393306 cites W1963826141 @default.
• W4308393306 cites W1983787599 @default.
• W4308393306 cites W1985264867 @default.
• W4308393306 cites W1998971866 @default.
• W4308393306 cites W2007528734 @default.
• W4308393306 cites W2007553857 @default.
• W4308393306 cites W2007649418 @default.
• W4308393306 cites W2016360721 @default.
• W4308393306 cites W2017081079 @default.
• W4308393306 cites W2022577027 @default.
• W4308393306 cites W2024502310 @default.
• W4308393306 cites W2035495099 @default.
• W4308393306 cites W2037690883 @default.
• W4308393306 cites W2039855270 @default.
• W4308393306 cites W2050211354 @default.
• W4308393306 cites W2088540000 @default.
• W4308393306 cites W2091134276 @default.
• W4308393306 cites W2096540669 @default.
• W4308393306 cites W2108042184 @default.
• W4308393306 cites W2117986690 @default.
• W4308393306 cites W2119351872 @default.
• W4308393306 cites W2124813314 @default.
• W4308393306 cites W2126177831 @default.
• W4308393306 cites W2126709309 @default.
• W4308393306 cites W2145618171 @default.
• W4308393306 cites W2154149901 @default.
• W4308393306 cites W2157824687 @default.
• W4308393306 cites W2167934111 @default.
• W4308393306 cites W2176128299 @default.
• W4308393306 cites W2218482236 @default.
• W4308393306 cites W2256191967 @default.
• W4308393306 cites W2270997383 @default.
• W4308393306 cites W2292957477 @default.
• W4308393306 cites W2376953009 @default.
• W4308393306 cites W2394893668 @default.
• W4308393306 cites W2400274474 @default.
• W4308393306 cites W2416111151 @default.
• W4308393306 cites W2468576628 @default.
• W4308393306 cites W2490543344 @default.
• W4308393306 cites W2513491150 @default.
• W4308393306 cites W2520051192 @default.
• W4308393306 cites W2536396512 @default.
• W4308393306 cites W2554688226 @default.
• W4308393306 cites W2560459637 @default.
• W4308393306 cites W2560717039 @default.
• W4308393306 cites W2566097899 @default.
• W4308393306 cites W2568710896 @default.
• W4308393306 cites W2578673768 @default.
• W4308393306 cites W2580557214 @default.
• W4308393306 cites W2585410541 @default.
• W4308393306 cites W2597231917 @default.
• W4308393306 cites W2603411876 @default.
• W4308393306 cites W2605556058 @default.
• W4308393306 cites W2606001457 @default.
• W4308393306 cites W2618035748 @default.
• W4308393306 cites W2624217133 @default.
• W4308393306 cites W2729330913 @default.
• W4308393306 cites W2736887233 @default.
• W4308393306 cites W2739122151 @default.
• W4308393306 cites W2739786760 @default.
• W4308393306 cites W2745035390 @default.
• W4308393306 cites W2747268799 @default.
• W4308393306 cites W2747965175 @default.
• W4308393306 cites W2748922433 @default.
• W4308393306 cites W2757581310 @default.
• W4308393306 cites W2759613714 @default.
• W4308393306 cites W2765920214 @default.
• W4308393306 cites W2770828094 @default.
• W4308393306 cites W2775356055 @default.
• W4308393306 cites W2781784785 @default.
• W4308393306 cites W2782863308 @default.
• W4308393306 cites W2785841326 @default.
• W4308393306 cites W2790922923 @default.
• W4308393306 cites W2792649477 @default.
• W4308393306 cites W2795832970 @default.
• W4308393306 cites W2796295138 @default.
• W4308393306 cites W2800623174 @default.
• W4308393306 cites W2805264144 @default.
• W4308393306 cites W2806889698 @default.
• W4308393306 cites W2808137450 @default.
• W4308393306 cites W2884601071 @default.
• W4308393306 cites W2887416920 @default.

• next